Recent Finacing
Recent Raise
Iconic Therapeutics is a clinical-stage biopharma developing tissue-factor-targeting fusion proteins (ICON-1/hI-con1) to treat neovascular retinal diseases like AMD and to initiate ocular melanoma and solid tumor programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors